Title:
【発明の名称】新規化合物、それらの製造及び使用
Document Type and Number:
Japanese Patent JP2003520839
Kind Code:
A
Abstract:
The present invention relates to compounds of formula (I). The compounds are useful in the treatment and/or prevention of conditions mediated by nuclear receptors, in particular the Peroxisome Proliferator-Activated Receptors (PPAR).
More Like This:
| WO/2022/107745 | THERAPEUTIC AGENT OR PROPHYLACTIC AGENT FOR COVID-19 |
| WO/2002/007720 | COMPOUNDS HAVING MIF ANTAGONIST ACTIVITY |
| WO/1998/058639 | SYNERGISTICALLY ACTING COMPOSITIONS FOR SELECTIVELY COMBATING TUMOR TISSUE |
Inventors:
Morgensen, John Patrick
Sauerberg, Pale
Barry, Paul Stanley
Jeppesen, Rhone
Petterson, Ingrid
Sauerberg, Pale
Barry, Paul Stanley
Jeppesen, Rhone
Petterson, Ingrid
Application Number:
JP2001555029A
Publication Date:
July 08, 2003
Filing Date:
January 26, 2001
Export Citation:
Assignee:
Novo Nordisk Actiesel Scab
International Classes:
A61K31/192; A61K31/216; A61K31/451; A61P3/04; A61P3/06; A61P3/10; A61P43/00; C07C51/367; C07C59/68; C07C67/31; C07C69/734; A61K45/00; (IPC1-7): C07C59/68; A61K31/192; A61K31/216; A61K31/451; A61K45/00; A61P3/04; A61P3/10; A61P43/00; C07C51/367; C07C67/31; C07C69/734
Attorney, Agent or Firm:
Takehiko Suzue (3 outside)